Hypokalemia

Hypokalemia

Watch later

Watch later

Parathyroid hormone
Calcitonin
Vitamin D
Insulin
Glucagon
Diabetes mellitus
Diabetes mellitus: Pathology review
Pancreatic neuroendocrine neoplasms
Hyperparathyroidism
Hypoparathyroidism
Parathyroid disorders and calcium imbalance: Pathology review
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Osteoporosis medications
Hypertrophic cardiomyopathy
Pigmentation skin disorders: Pathology review
Albinism
Thymus histology
Glomerular filtration
Measuring renal plasma flow and renal blood flow
Thyroglossal duct cyst
Bowel obstruction
Platelet plug formation (primary hemostasis)
Anatomy of the abdominal viscera: Kidneys, ureters and suprarenal glands
Anatomy of the perineum
Thiazide and thiazide-like diuretics
Vaginal and vulvar disorders: Pathology review
Alpha-thalassemia
Spleen histology
Fallopian tube and uterus histology
Mammary gland histology
Ovary histology
Brucella
Oral cancer
Oxygen binding capacity and oxygen content
Obstructive lung diseases: Pathology review
Ehrlichia and Anaplasma
Myeloproliferative disorders: Pathology review
Nervous system anatomy and physiology
Hyperkalemia
Dementia: Pathology review
Anatomy of the heart
Anatomy of the coronary circulation
Anatomy clinical correlates: Heart
Anatomy clinical correlates: Mediastinum
Infectious endocarditis: Clinical sciences
Infective endocarditis: Clinical
Endocarditis
Endocarditis: Pathology review
Development of the respiratory system
Adenovirus
Anatomy of the arm
Perinatal infections: Clinical
Dyslipidemias: Pathology review
Acyanotic congenital heart defects: Pathology review
Blood pressure, blood flow, and resistance
ECG basics
Development of the cardiovascular system
Fetal circulation
Calcium channel blockers
Anatomy of the eye
Introduction to the cranial nerves
Cranial nerve pathways
Anatomy of the olfactory (CN I) and optic (CN II) nerves
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy of the glossopharyngeal nerve (CN IX)
Anatomy of the vagus nerve (CN X)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Actinomyces israelii
Clostridium botulinum (Botulism)
Clostridium tetani (Tetanus)
Haemophilus influenzae
Listeria monocytogenes
Mycobacterium tuberculosis (Tuberculosis)
Neisseria meningitidis
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Central nervous system histology
Peripheral nervous system histology
Eye and ear histology
Coxsackievirus
Cytomegalovirus
Eastern and Western equine encephalitis virus
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
JC virus (Progressive multifocal leukoencephalopathy)
Lymphocytic choriomeningitis virus
Measles virus
Mumps virus
Poliovirus
Rabies virus
Varicella zoster virus
West Nile virus
Acute disseminated encephalomyelitis
Central pontine myelinolysis
Multiple sclerosis
Transverse myelitis
Charcot-Marie-Tooth disease
Guillain-Barre syndrome
Adult brain tumors
Neurofibromatosis
Pediatric brain tumors
Pituitary adenoma
Sympathomimetics: Direct agonists
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Cardiac muscle histology
Mesothelioma
Nasal polyps
Nasopharyngeal carcinoma
Pancoast tumor
Superior vena cava syndrome
Cystic fibrosis: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Lung cancer and mesothelioma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Respiratory distress syndrome: Pathology review
Adrenergic antagonists: Presynaptic
Adrenergic receptors
Cholinergic receptors
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympatholytics: Alpha-2 agonists
Introduction to the immune system
Gallbladder disorders: Pathology review
Anatomy of the thyroid and parathyroid glands
Acute coronary syndrome: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to hypertension: Clinical sciences
Coronary artery disease: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Tobacco use: Clinical sciences
Ketone body metabolism
Kidney histology
Ureter, bladder and urethra histology
Bladder exstrophy
Horseshoe kidney
Hydronephrosis
Hypospadias and epispadias
Potter sequence
Renal agenesis
Alport syndrome
Goodpasture syndrome
IgA nephropathy (NORD)
Lupus nephritis
Poststreptococcal glomerulonephritis
Rapidly progressive glomerulonephritis
Amyloidosis
Diabetic nephropathy
Focal segmental glomerulosclerosis (NORD)
Membranoproliferative glomerulonephritis
Membranous nephropathy
Minimal change disease
Acute tubular necrosis
Renal papillary necrosis
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Postrenal azotemia
Prerenal azotemia
Renal azotemia
Chronic kidney disease
Kidney stones
Renal tubular acidosis
Angiomyolipoma
Medullary cystic kidney disease
Medullary sponge kidney
Multicystic dysplastic kidney
Polycystic kidney disease
Beckwith-Wiedemann syndrome
Nephroblastoma (Wilms tumor)
Non-urothelial bladder cancers
Renal cell carcinoma
Transitional cell carcinoma
WAGR syndrome
Neurogenic bladder
Posterior urethral valves
Urinary incontinence
Vesicoureteral reflux
Renal artery stenosis
Renal cortical necrosis
Metabolic acidosis
Metabolic alkalosis
Respiratory acidosis
Respiratory alkalosis
Hypercalcemia
Hypermagnesemia
Hypernatremia
Hyperphosphatemia
Hypocalcemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypophosphatemia
Congenital renal disorders: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Urinary tract infections: Pathology review
Kidney stones: Pathology review
Renal failure: Pathology review
Renal tubular acidosis: Pathology review
Renal tubular defects: Pathology review
Renal and urinary tract masses: Pathology review
Urinary incontinence: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Appendicitis
Abdominal hernias
Inguinal hernias: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Ventral and incisional hernias: Clinical sciences
Inguinal hernia
Femoral hernia
Acute pancreatitis: Clinical sciences
Cholecystitis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Anticoagulants: Warfarin
Factor V Leiden

Transcript

Watch video only

With hypokalemia, hypo- means under and -kal- refers to potassium, and -emia refers to the blood, so hypokalemia means lower than normal potassium levels in the blood, generally under 3.5 mEq/L.

Now, total body potassium can essentially be split into two components—intracellular and extracellular potassium, or potassium inside and outside cells, respectively.

The extracellular component includes both the intravascular space, which is the space within the blood and lymphatic vessels and the interstitial space—the space between cells where you typically find fibrous proteins and long chains of carbohydrates which are called glycosaminoglycans.

Now, the vast majority, around 98%, of all of the body’s potassium is intracellular, or inside of the cells.

In fact, the concentration of potassium inside the cells is about 150 mEq/L whereas outside the cells it’s only about 4.5 mEq/L.

Keep in mind that these potassium ions carry a charge, so the difference in concentration also leads to a difference in charge, which establishes an overall electrochemical gradient across the cell membrane.

And this is called the internal potassium balance. This balance is maintained by the sodium-potassium pump, which pumps 2 potassium ions in for every 3 sodium ions out, as well as potassium leak channels and inward rectifier channels that are scattered throughout the membrane.

This concentration gradient is extremely important for setting the resting membrane potential of excitable cell membranes, which is needed for normal contraction of smooth, cardiac, and skeletal muscle.

Also, though, in addition to this internal potassium balance, there’s also an external potassium balance, which refers to the potassium you get externally through the diet every day.

On a daily basis the amount of potassium that typically gets taken in, usually ranges between 50 mEq/L to 150 mEq/L, which is way higher than the extracellular potassium concentration of 4.5 mEq/L, so your body has to figure out a way to excrete most of what it takes in.

This external balancing act is largely taken care of by the kidneys, where excess potassium is secreted into a renal tubule and excreted in the urine.

Also, though, a small amount dietary potassium is also lost via the gastrointestinal tract and the sweat.

So, in order for there to be too little potassium in the blood, or hypokalemia, there are two possibilities, the first is an external balance shift most often caused by an increase in potassium excretion in the kidneys, which lowers the level of potassium in the blood, and the second is an internal balance shift where potassium moves into of cells, from the interstitium and blood.

One potential cause of an internal potassium balance shift is having excess insulin.

This is because, after a meal, glucose increases in the blood, and at the same time insulin’s released, which binds to cells and stimulates the uptake of that glucose.

Insulin also increases the activity of the sodium/potassium pump, which pulls potassium into cells.

People with type I diabetes don’t make enough insulin, and so they use exogenous insulin, meaning an injection or infusion of insulin.

In rare cases, insulin overdose can cause enough potassium uptake into cells as to cause hypokalemia.

Another cause of an internal potassium balance shift could be an alkalosis, which is when the blood becomes too alkaline, in other words, there’s a lower concentration of hydrogen ions—meaning a higher blood pH.

One way the body can decrease blood pH is by moving hydrogen ions out of cells and into the blood.

To accomplish this, cells use a complex series of multiple ion channels, exchangers, and pumps to exchange hydrogen ions for potassium ions across the cell membrane.

So in order to help compensate for an alkalosis, hydrogen ions leave cells and potassium ions enter the cells and leave the blood, resulting in hypokalemia.

That being said, not all acid-base disturbances affect potassium levels.

For example, in respiratory alkalosis due to low carbon dioxide levels in the blood, potassium levels aren’t typically affected because CO2 is lipid soluble and freely moves into or out of cells without being exchanged for potassium, therefore no hypokalemia.

Certain catecholamines can also shift potassium movement into cells, and this is via the beta-2-adrenergic and alpha-adrenergic receptors on cell membranes.

When activated, beta-2-adrenergic receptors stimulate the sodium-potassium pump, which pulls potassium from the blood into cells.

Meanwhile alpha-adrenergic receptors cause a shift of potassium out of cells via calcium-dependent potassium channels.

So, that said, beta-2-adrenergic agonists and alpha-adrenergic antagonists, both cause a shift in potassium into cells and out of the blood.

Alright, on to external potassium balance shifts resulting in hypokalemia, which has to do with potassium intake or excretion.

With regards to intake, simply not taking enough potassium in can lead to hypokalemia, like in the case of anorexia, prolonged fasting, or specific types of diets.

Most other cases, though, have to do with the kidney’s ability to regulate what stays in the blood and gets excreted into the urine.

The kidney does this by the processes of filtration, reabsorption, and secretion in the nephron.

First off, potassium is freely filtered from the blood into the urine at the glomerulus.

After that, about 67% is reabsorbed in the proximal convoluted tubule, and an additional 20% is reabsorbed in the thick ascending limb.